How much funding has Biofourmis raised?

Biofourmis has raised $461.5M in total funding, most recently a Series D round.

Who are Biofourmis's investors?

Biofourmis's investors include Sequoia Capital, General Atlantic, SoftBank, Aviva, NSI Ventures, EDBI.

When was Biofourmis founded?

Biofourmis was founded in 2015.

Where is Biofourmis headquartered?

Biofourmis is headquartered in Boston, Massachusetts, United States.

How many employees does Biofourmis have?

Biofourmis has 201-500 employees.

Biofourmis

Q: What industry is Biofourmis in?

Biofourmis operates in Artificial Intelligence, Digital Health, Healthcare, Life Sciences, Biotech.

Acquired

Revolutionize the delivery of care

Boston, United States · Founded 2015 · $461.5M raised

Artificial Intelligence

Headquarters: Boston, Massachusetts
Employees: 201–500
Founded: 2015
Business Model: B2B

Website: biofourmis.com
Total Funding: $461.5M
Last Round: $20.0M Series DJul 2022
Rounds: 7

About

Biofourmis is a technology-enabled care delivery company partnering with over 50 health systems and payers globally. Its AI-powered platform supports hospital-at-home, remote patient monitoring, and digital clinical trials, enabling 70% reductions in 30-day readmissions and up to 38% cost-of-care reductions. Following a 2024 merger with CopilotIQ, it offers end-to-end AI-driven in-home care.

Summary

Biofourmis is an Artificial Intelligence company based in Boston, United States, founded in 2015. It has raised $461.5M in total across 7 rounds, most recently a $20.0M Series D round in Jul 2022. Investors include Sequoia Capital, General Atlantic and SoftBank.

LinkedIn X (Twitter)